SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-022661
Filing Date
2024-02-02
Accepted
2024-02-02 12:31:26
Documents
1
Group Members
3X5 RIVERVEST FUND II, L.P.3X5 RIVERVEST FUND II-B, L.P.3X5 RIVERVEST PARTNERS II, LLCJAY SCHMELTERJOHN P. MCKEARN, PH.D.RIVERVEST 3X5 MANAGERS II, L.P.RIVERVEST 3X5 MANAGERS II, LLCRIVERVEST VENTURE FUND II (OHIO), L.P.RIVERVEST VENTURE FUND II, L.P.RIVE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d700021dsc13da.htm SC 13D/A 371768
  Complete submission text file 0001193125-24-022661.txt   374150
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Subject) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90578 | Film No.: 24589681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105
Business Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105 314-726-6700
RiverVest Venture Fund III, L.P. (Filed by) CIK: 0001601559 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A